80 related articles for article (PubMed ID: 3137644)
1. [Administration of high doses of cisplatin in 20-minute infusions].
Cirera L; Gay M; Tomé T; Martí M; Huguet J; Plá R
Rev Clin Esp; 1988 Mar; 182(4):192-5. PubMed ID: 3137644
[No Abstract] [Full Text] [Related]
2. Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial.
Santoso JT; Lucci JA; Coleman RL; Schafer I; Hannigan EV
Cancer Chemother Pharmacol; 2003 Jul; 52(1):13-8. PubMed ID: 12719883
[TBL] [Abstract][Full Text] [Related]
3. Comparison of oral and intravenous hydration and diuretic, choice for protecting cisplatin induced nephrotoxicity.
Dana R; Kachhwaha VS
Indian J Cancer; 1996 Dec; 33(4):168-70. PubMed ID: 9254992
[TBL] [Abstract][Full Text] [Related]
4. Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin.
Cornelison TL; Reed E
Gynecol Oncol; 1993 Aug; 50(2):147-58. PubMed ID: 8375728
[TBL] [Abstract][Full Text] [Related]
5. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
6. Prevention of cisplatin-induced nephrotoxicosis in dogs, using hypertonic saline solution as the vehicle of administration.
Forrester SD; Fallin EA; Saunders GK; Kenny JE
Am J Vet Res; 1993 Dec; 54(12):2175-8. PubMed ID: 8116956
[TBL] [Abstract][Full Text] [Related]
7. Safe and effective two-hour outpatient regimen of hydration and diuresis for the administration of cis-diamminedichloroplatinum (II).
Vogl SE; Zaravinos T; Kaplan BH; Wollner D
Eur J Cancer (1965); 1981 Mar; 17(3):345-50. PubMed ID: 6790287
[No Abstract] [Full Text] [Related]
8. High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity.
Ostrow S; Egorin MJ; Hahn D; Markus S; Aisner J; Chang P; LeRoy A; Bachur NR; Wiernik PH
Cancer Treat Rep; 1981; 65(1-2):73-8. PubMed ID: 6784924
[TBL] [Abstract][Full Text] [Related]
9. [Cisplatin in the treatment of malignant tumors].
Wang QL
Zhonghua Zhong Liu Za Zhi; 1983 Nov; 5(6):461-4. PubMed ID: 6426911
[No Abstract] [Full Text] [Related]
10. Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study.
Al-Sarraf M; Fletcher W; Oishi N; Pugh R; Hewlett JS; Balducci L; McCracken J; Padilla F
Cancer Treat Rep; 1982 Jan; 66(1):31-5. PubMed ID: 6796269
[TBL] [Abstract][Full Text] [Related]
11. [Antitumor effectiveness and nephrotoxicity of oxoplatinum].
Aref'eva AK; Rykov VA; Mitrokhina LN
Vopr Onkol; 1990; 36(3):331-4. PubMed ID: 2109913
[TBL] [Abstract][Full Text] [Related]
12. Hypertonic saline: a novel therapy for advanced heart failure?
Drazner MH; Palmer BF
Am Heart J; 2003 Mar; 145(3):377-9. PubMed ID: 12660656
[No Abstract] [Full Text] [Related]
13. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
[TBL] [Abstract][Full Text] [Related]
14. [The protective effects of two hydration protocols against cisplatin nephrotoxicity].
Guo JH; Song ST; Xu ZL
Zhonghua Zhong Liu Za Zhi; 1994 Jan; 16(1):56-8. PubMed ID: 8033751
[TBL] [Abstract][Full Text] [Related]
15. Small-volume resuscitation with hypertonic sodium colloid solution--what does clinical routine tell us?
Kreimeier U; Messmer K
Wien Klin Wochenschr; 2002 Feb; 114(3):76-7. PubMed ID: 12060971
[No Abstract] [Full Text] [Related]
16. Furosemide versus mannitol in Japanese patients with thoracic malignancy who received cisplatin-based chemotherapy using short hydration: study protocol for a randomised controlled trial.
Murakami E; Akamatsu H; Shimokawa T; Wada K; Yamamoto N
BMJ Open; 2019 Dec; 9(12):e029057. PubMed ID: 31831529
[TBL] [Abstract][Full Text] [Related]
17. High-dose furosemide and small-volume hypertonic saline solution infusion for the treatment of leg edema in advanced cancer patients.
Mercadante S; Villari P; Ferrera P; David F; Intravaia G
J Pain Symptom Manage; 2009 Mar; 37(3):419-23. PubMed ID: 18790601
[TBL] [Abstract][Full Text] [Related]
18. Nephroprotection by theophylline in patients with cisplatin chemotherapy: a randomized, single-blinded, placebo-controlled trial.
Benoehr P; Krueth P; Bokemeyer C; Grenz A; Osswald H; Hartmann JT
J Am Soc Nephrol; 2005 Feb; 16(2):452-8. PubMed ID: 15590762
[TBL] [Abstract][Full Text] [Related]
19. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
[TBL] [Abstract][Full Text] [Related]
20. [Low-volume infusion therapy with hyperosmolar sodium chloride solutions in the treatment of acute massive blood loss].
Tsybuliak GN; Chechetkin AV
Vestn Khir Im I I Grek; 1999; 158(2):73-6. PubMed ID: 10368901
[No Abstract] [Full Text] [Related]
[Next] [New Search]
